ICG camera dye test during surgery for advanced stomach cancer
Part of Cancer, Digestive system clinical trials.
This trial tests whether an “ICG” dye and special camera can help surgeons see cancer more clearly during surgery for advanced stomach cancer. It may help improve how safely and accurately surgeons remove the tumor and nearby lymph nodes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You have stomach cancer confirmed by biopsy, located in the upper, middle, or lower stomach.
- Your cancer is considered “advanced” but has not spread to distant organs, and surgery can be done with a minimally invasive distal or total gastrectomy plus lymph node removal.
- There should be no signs (before or during surgery) that the cancer has spread to far-away organs or directly grown into nearby organs like the pancreas or spleen.
- You must be able to give written consent.
- You should not be pregnant, breastfeeding, or allergic to iodine-type medicines.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new imaging dye that helps surgeons see exactly where the tumor ends during stomach cancer surgery. It aims to remove all cancer cells while sparing healthy tissue, which may lead to a more precise operation.
This trial tests whether using a special dye (called indocyanine green) during a minimally invasive laparoscopic surgery can help doctors see lymph nodes and cancer more clearly in patients with upper stomach cancer. The goal is to improve the precision of the surgery and possibly lead to better outcomes.
This trial tests a new way to remove stomach cancer using 3D-4K cameras and a special dye during laparoscopic (keyhole) surgery. It may help surgeons see the cancer better and remove it more precisely.
This trial tests whether a green dye called indocyanine green can help surgeons find and remove more lymph nodes during laparoscopic surgery for advanced stomach cancer. It may improve the chances of removing all cancer.
This trial tests whether using a green dye (called indocyanine green) during minimally invasive surgery can help the surgeon see and remove lymph nodes more effectively for stomach cancer. The dye is injected near the tumor and may improve the accuracy of lymph node removal, which could help reduce the risk of cancer coming back.
This Phase 2 study tests whether using a special light-activated dye (indocyanine green) during laparoscopic stomach surgery can improve surgical outcomes for people with remnant (leftover) stomach cancer that has not spread to distant organs. It may help surgeons better find lymph nodes while operating.
Hear when a new Gastric Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.